SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001011438-17-000102
Filing Date
2017-02-13
Accepted
2017-02-13 16:02:56
Documents
1
Group Members
CADIAN CAPITAL MANAGEMENT GP, LLCERIC BANNASCH

Document Format Files

Seq Description Document Type Size
1 form_sc13ga-adverumbio.htm SC 13G/A 186562
  Complete submission text file 0001011438-17-000102.txt   188338
Mailing Address 535 MADISON AVENUE, 36TH FLOOR NEW YORK NY 10022
Business Address 535 MADISON AVENUE, 36TH FLOOR NEW YORK NY 10022 212-792-8800
CADIAN CAPITAL MANAGEMENT, LP (Filed by) CIK: 0001423686 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 1035 O'BRIEN DRIVE MENLO PARK CA 94025
Business Address 1035 O'BRIEN DRIVE MENLO PARK CA 94025 650-272-6269
Adverum Biotechnologies, Inc. (Subject) CIK: 0001501756 (see all company filings)

IRS No.: 205258327 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88266 | Film No.: 17598974
SIC: 2836 Biological Products, (No Diagnostic Substances)